Neurocrine Biosciences (NBIX)

• Market cap: $14.3B
• 1 day: 3.75%
• 5 days: -1.23%
• 1 month: 2.02%
• 3 months: 11.68%
• 6 months: 32.98%
• Year to date: 3.88%
• 1 year: 19.07%
• 5 years: 49.21%
• 10 years: 173.2%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.

Employees: 1,800